Aviva platform continues development of innovative technology to support advisers.The latest innovation, the Aviva Analytics tool, is now live with selected…
Extended Phase 1b trial follow-up on IMA203 PRAME cell therapy in 33 heavily pretreated patients with metastatic melanoma demonstrates favorable…